Recurrent Hypopharyngeal Cancer Completed Phase 1 / 2 Trials for Fludeoxyglucose (DB15107)

Also known as: Hypopharyngeal cancer recurrent / Malignant neoplasm of hypopharynx recurrent

IndicationStatusPhase
DBCOND0062578 (Recurrent Hypopharyngeal Cancer)Completed1 / 2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT0180667518F-FPPRGD2 PET/CT or PET/MRI in Predicting Early Response in Patients With Cancer Receiving Anti-Angiogenesis TherapyDiagnostic